The 10 most recent market catalysts affecting $UHS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 18, 2026
Corporate Catalyst
Bullish
Impact 55
Leerink Partners Maintains Outperform on Universal Health Services, Raises Price Target to $205
Leerink Partners analyst Whit Mayo maintained an 'Outperform' rating on Universal Health Services (UHS) and raised the price target from $198 to $205. This action signals continued…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 55
Goldman Sachs Maintains Neutral on Universal Health Services, Lowers Price Target to $190
Goldman Sachs, through analyst Scott Fidel, has maintained its 'Neutral' rating on Universal Health Services (UHS) but has notably cut its price target from $242 to $190. This acti…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 75
These Analysts Slash Their Forecasts On Universal Health Services Following Q2 Earnings
Universal Health Services (UHS) delivered a mixed Q2 report, exceeding analyst estimates for both earnings per share and revenue. However, the positive Q2 performance was overshado…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 55
Baird Maintains Neutral on Universal Health Services, Lowers Price Target to $166
Baird analyst Michael Ha maintained a 'Neutral' rating on Universal Health Services (UHS) but notably reduced the price target from $204 to $166. This action indicates a revised va…
Jul 28, 2026
Corporate Catalyst
Bearish
Impact 75
Universal Health Services shares are trading lower after the company reported Q2 financial results and cut its FY26 adjusted EPS guidance. Barclays lowered its price target on the stock from $179 to $168.
This headline indicates a significant negative corporate catalyst for Universal Health Services. The combination of weaker-than-expected Q2 financial results and a downward revisio…
Jul 28, 2026
Macro/Central Bank
Bearish
Impact 65
Stock Market Today: Dow Jones Futures Gain as Coca-Cola Jumps After Q2 Beat, S&P 500, Nasdaq 100 Decline—Boeing, Johnson & Johnson in Focus (UPDATED)
The filing provides a snapshot of the market's opening sentiment, influenced by a mix of economic data, geopolitical headlines, and individual company earnings. The narrowing trade…
Jul 27, 2026
Corporate Catalyst
Bearish
Impact 85
Universal Health Services shares are trading lower after the company reported Q2 financial results and cut its FY26 adjusted EPS guidance.
The headline signals a significant negative corporate catalyst for Universal Health Services. Lowered guidance for future earnings is a strong indicator of potential headwinds, suc…
Jul 27, 2026
Corporate Catalyst
Bearish
Impact 75
UPDATE : Universal Health Services Lowers FY2026 Adj EPS Guidance from $22.64-$24.52 to $22.28-$23.65 vs $23.45 Est; Narrows FY2026 Sales Guidance from $18.417B-$18.789B to $18.501B-$18.762B vs $18.524B Est
Universal Health Services (UHS) has updated its financial guidance for fiscal year 2026, specifically lowering its adjusted EPS range from $22.64-$24.52 to $22.28-$23.65. This new …
Jul 27, 2026
Corporate Catalyst
Bearish
Impact 75
Universal Health Services Lowers FY2026 Adj EPS Guidance from $22.64-$24.52 to $22.28-$23.65 vs $23.45 Est
Universal Health Services (UHS) announced a reduction in its adjusted EPS guidance for fiscal year 2026. The revised range of $22.28-$23.65 is notably lower than their previous gui…
Jul 27, 2026
Corporate Catalyst
Bullish
Impact 92
Universal Health Servs Q2 Adj. EPS $5.98 Beats $5.96 Estimate, Sales $4.638B Beat $4.577B Estimate
Universal Health Services (UHS) announced Q2 adjusted EPS of $5.98, surpassing the $5.96 consensus estimate, and sales of $4.638 billion, beating the $4.577 billion estimate. This …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.